Microsoft word - apendix_phase3.doc
Copyright 2003 ICARE, All rights reserved. Contact: jmcgowa@sph.emory.edu
ABBREVIATIONS USED IN ICARE ANALYSIS
Antimicrobial Groups
Antimicrobial / Group
Abbreviation
Methicillin group :
Methicillin, Nafcillin, Oxacillin, Cloxacillin (oral),
Dicloxacillin (oral)
Ampicillin group :
Ampicillin (parenteral, oral), Ampicillin/Sulbactam
Amoxicillin (oral), Amoxicillin/Clav. Acid (oral)
Fluoroquinolones :
Ciprofloxacin (parental, oral), Ofloxacin (parental, oral)
Levofloxacin (parenteral, oral), Trovafloxacin (parenteral, oral),
Sparfloxacin (oral)
Ureido- and carboxy-penicillins :
Pipercillin, Pipercillin/Tazobactam,
Copyright 2003 ICARE, All rights reserved. Contact: jmcgowa@sph.emory.edu
Ureido-penicillins :
Pipercillin, Pipercillin/Tazobactam
Trimethoprim-Sulfamethoxazole
1st generation cephalosporins :
Cefazolin, Cefadroxil (oral), Cephalothin, Cephalexin (oral)
2nd generation cephalosporins :
Cefotetan, Cefmetazole, Cefaclor (oral),
Cefoxitin, Cefuroxime, Cefuroxime axetil (oral)
3rd generation cephalosporins :
Cefotaxime, Cefixime (oral), Ceftazidime,
Ceftizoxime, Ceftriaxone, Cefoperazone, Cefipime
Ciprofloxacin group:
Ciprofloxacin (parenteral), Ciprofloxacin (oral)
Ceftazidime (also analyzed independently)
Oral Fluoroquinolones :
Ciprofloxacin, Ofloxacin, Levofloxacin,
Trovafloxacin, Sparfloxacin
Parenteral Fluoroquinolones :
Ciprofloxacin, Ofloxacin, Levofloxacin,
Trovafloxacin
Carbapenems :
Antimicrobial/Pathogen Pai r
Antimicrobial / Pathogen
Abbreviation
Methicillin-resistant Staphylococcus aureus
Methicillin-resistant coagulase-negative Staphylococci CNS_ME
Vancomycin-resistant Enterococci
Penicillin-resistant Streptococcus pneumoniae
Cefotaxime or Ceftriaxone-resistant
Streptococcus pneumoniae Ciprofloxacin-resistant Pseudomonas aeruginosa
Imipenem-resistant Pseudomonas aeruginosa
Ceftazidime-resistant Pseudomonas aeruginosa
Piperacillin-resistant Pseudomonas aeruginosa
Meropenem-resistant Pseudomonas aeruginosa
Ofloxacin-resistant Pseudomonas aeruginosa
Levofloxacin-resistant Pseudomonas aeruginosa
Copyright 2003 ICARE, All rights reserved. Contact: jmcgowa@sph.emory.edu
Ceftazidime, Cefotaxime, or Ceftriaxone-resistant
Escherichia coli Ceftazidime, Cefotaxime, or Ceftriaxone-resistant
Enterobacter spp. Ceftazidime, Cefotaxime, or Ceftriaxone-resistant
Klebsiella pneumoniae Ciprofloxacin, Ofloxacin, or Levofloxacin-resistant
Escherichia coli Imipenem or Meropenem-resistant
CLASS, GROUPING, AND DEFINED DAILY DOSE (DDD) OF
ANTIMICROBIAL AGENT
Antimicrobial Agent
DDD 12 x 106
Copyright 2003 ICARE, All rights reserved. Contact: jmcgowa@sph.emory.edu
Source: http://web1.sph.emory.edu/ICARE/PDFPhaseIII_Apendix.pdf
STATE OF THE MUNICIPAL ADDRESS MASERUMULA PARK SPORT GROUND 06 MARCH 2009 10:00 By CLLR. Q.E. MOKHABELA MAYOR OF MAKHUDUTHAMAGA LOCAL MUNICIPALITY SOMA 2009 MAKHUDUTHAMAGA MUNICIPALITY Page 1 of 13 MADAM SPEAKER HOUNORABLE MEC OF LOCAL GOVERNMENT AND HOUSING, MAITE NKOANA-MASHABANE EXECUTIVE COMMITTEE MEMBERS CHIEF WHIP AND COUNCILORS TRADITIONAL LEADER
PATIENT INFORMATION Patient Name Patient ID Diagnosis Referring Physician Exam Date Accession Number Primary Medication Secondary Medication As-Needed Medication As-Needed Medication NEUROTYPE GROUP Efficacy Type Resilience Type Focus Type Acceptance Type RECOMMENDED PAIN CONTROL COGNITIVE STRATEGIES NEUROTYPE GROUP
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |